These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35902323)

  • 21. Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: long-term performance and complications.
    Winter J; Siekiera M; Shin DI; Meyer C; Kröpil P; Clahsen H; O'Connor S
    Europace; 2017 Dec; 19(12):2036-2041. PubMed ID: 28007749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator?
    van der Stuijt W; Pepplinkhuizen S; de Veld JA; Quast ABE; van Halm VP; Bijsterveld NR; Olde Nordkamp LRA; Wilde AAM; Smeding L; Knops RE
    Int J Cardiol; 2024 Mar; 398():131639. PubMed ID: 38065323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative Prediction of Shock Impedance for Subcutaneous Implantable Cardioverter Defibrillator Using Chest Computed Tomography.
    Kasagawa A; Nakajima I; Nakayama Y; Togashi D; Sasaki K; Matsuda H; Harada T; Akashi YJ
    Circ J; 2024 Jun; 88(7):1147-1154. PubMed ID: 38311419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique.
    Francia P; Adduci C; Angeletti A; Ottaviano L; Perrotta L; De Vivo S; Bongiorni MG; Migliore F; Russo AD; De Filippo P; Caravati F; Nigro G; Palmisano P; Viani S; D'Onofrio A; Lovecchio M; Valsecchi S; Ziacchi M
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1695-1703. PubMed ID: 33969578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.
    Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN
    Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator.
    Frankel DS; Burke MC; Callans DJ; Stivland TM; Duffy E; Epstein AE
    JACC Clin Electrophysiol; 2018 May; 4(5):652-659. PubMed ID: 29798794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermuscular two-incision technique for implantation of the subcutaneous implantable cardioverter defibrillator: a 3-year follow-up.
    Migliore F; Pittorru R; Giacomin E; Dall'Aglio PB; Falzone PV; Bertaglia E; Iliceto S; Gregori D; De Lazzari M; Corrado D
    J Interv Card Electrophysiol; 2023 Jan; ():. PubMed ID: 36662384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary rates and outcomes of single- vs. dual-coil implantable cardioverter defibrillator lead implantation: data from the Israeli ICD Registry.
    Leshem E; Suleiman M; Laish-Farkash A; Konstantino Y; Glikson M; Barsheshet A; Goldenberg I; Michowitz Y;
    Europace; 2017 Sep; 19(9):1485-1492. PubMed ID: 27702848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous air entrapment after subcutaneous implantable cardioverter defibrillator implantation evaluated by computed tomography.
    Taguchi Y; Ishikawa T; Matsumoto K; Narikawa M; Okazaki Y; Miyagawa S; Horigome A; Hosoda J
    Pacing Clin Electrophysiol; 2024 Apr; 47(4):496-502. PubMed ID: 38462721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort.
    Ruwald MH; Ruwald AC; Johansen JB; Gislason G; Nielsen JC; Philbert B; Riahi S; Vinther M; Lindhardt TB
    Europace; 2019 Aug; 21(8):1211-1219. PubMed ID: 31329849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: Long-term complications, replacements, and battery longevity.
    Quast ABE; van Dijk VF; Yap SC; Maass AH; Boersma LVA; Theuns DA; Knops RE
    J Cardiovasc Electrophysiol; 2018 Jul; 29(7):1010-1016. PubMed ID: 29626366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator: An Evaluation of 4 Implantation Techniques.
    Brouwer TF; Miller MA; Quast AB; Palaniswamy C; Dukkipati SR; Reddy V; Wilde AA; Willner JM; Knops RE
    Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):e004663. PubMed ID: 28073910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing elevated subcutaneous implantable cardioverter-defibrillator defibrillation thresholds: The importance of implantation technique.
    Ip JE
    J Cardiovasc Electrophysiol; 2021 Apr; 32(4):1205-1208. PubMed ID: 33484227
    [No Abstract]   [Full Text] [Related]  

  • 37. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study.
    Baccillieri MS; Gasparini G; Benacchio L; Zorzi A; Marras E; Zerbo F; Tomasi L; Vaccari D; Pastore G; Bonanno C; Molon G; Zanotto G; Fusco A; Carasi M; Zorzi A; Calzolari V; Ignatiuk B; Cannas S; Vaglio A; Al Bunni M; Pedrini A; Olivieri A; Rampazzo R; Minicuci N; Corrado D; Verlato R
    J Interv Card Electrophysiol; 2015 Jun; 43(1):45-54. PubMed ID: 25690336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
    Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
    BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of non-transvenous cardioverter defibrillators in infants and young children.
    Müller MJ; Dieks JK; Backhoff D; Schneider HE; Ruschewski W; Tirilomis T; Paul T; Krause U
    J Interv Card Electrophysiol; 2019 Mar; 54(2):151-159. PubMed ID: 30255451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.